Tarlatamab and the Future of Immunotherapy: A New Approach to Small Cell Lung Cancer
Saved in:
| Main Authors: | , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Elsevier
2025-01-01
|
| Series: | Current Therapeutic Research |
| Subjects: | |
| Online Access: | http://www.sciencedirect.com/science/article/pii/S0011393X24000432 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1841544034838904832 |
|---|---|
| author | Raza Ur Rehman, MBBS Ahmad Furqan Anjum, MBBS Rida Fatima, MBBS |
| author_facet | Raza Ur Rehman, MBBS Ahmad Furqan Anjum, MBBS Rida Fatima, MBBS |
| author_sort | Raza Ur Rehman, MBBS |
| collection | DOAJ |
| format | Article |
| id | doaj-art-1d17ff7c5f3f4df29652464ae10a9c8e |
| institution | Kabale University |
| issn | 0011-393X |
| language | English |
| publishDate | 2025-01-01 |
| publisher | Elsevier |
| record_format | Article |
| series | Current Therapeutic Research |
| spelling | doaj-art-1d17ff7c5f3f4df29652464ae10a9c8e2025-01-13T04:18:16ZengElsevierCurrent Therapeutic Research0011-393X2025-01-01102100773Tarlatamab and the Future of Immunotherapy: A New Approach to Small Cell Lung CancerRaza Ur Rehman, MBBS0Ahmad Furqan Anjum, MBBS1Rida Fatima, MBBS2Address correspondence to: Shaikh Khalifa Bin Zayed Al-Nahyan Medical and Dental College, Lahore.; Shaikh Khalifa Bin Zayed Al-Nahyan Medical and Dental College, Lahore, Punjab, PakistanShaikh Khalifa Bin Zayed Al-Nahyan Medical and Dental College, Lahore, Punjab, PakistanShaikh Khalifa Bin Zayed Al-Nahyan Medical and Dental College, Lahore, Punjab, Pakistanhttp://www.sciencedirect.com/science/article/pii/S0011393X24000432Bispecific T-cell engagerDLL3 proteinFDA approvalImmunotherapySmall cell Lung cancer (SCLC)Tarlatamab |
| spellingShingle | Raza Ur Rehman, MBBS Ahmad Furqan Anjum, MBBS Rida Fatima, MBBS Tarlatamab and the Future of Immunotherapy: A New Approach to Small Cell Lung Cancer Current Therapeutic Research Bispecific T-cell engager DLL3 protein FDA approval Immunotherapy Small cell Lung cancer (SCLC) Tarlatamab |
| title | Tarlatamab and the Future of Immunotherapy: A New Approach to Small Cell Lung Cancer |
| title_full | Tarlatamab and the Future of Immunotherapy: A New Approach to Small Cell Lung Cancer |
| title_fullStr | Tarlatamab and the Future of Immunotherapy: A New Approach to Small Cell Lung Cancer |
| title_full_unstemmed | Tarlatamab and the Future of Immunotherapy: A New Approach to Small Cell Lung Cancer |
| title_short | Tarlatamab and the Future of Immunotherapy: A New Approach to Small Cell Lung Cancer |
| title_sort | tarlatamab and the future of immunotherapy a new approach to small cell lung cancer |
| topic | Bispecific T-cell engager DLL3 protein FDA approval Immunotherapy Small cell Lung cancer (SCLC) Tarlatamab |
| url | http://www.sciencedirect.com/science/article/pii/S0011393X24000432 |
| work_keys_str_mv | AT razaurrehmanmbbs tarlatamabandthefutureofimmunotherapyanewapproachtosmallcelllungcancer AT ahmadfurqananjummbbs tarlatamabandthefutureofimmunotherapyanewapproachtosmallcelllungcancer AT ridafatimambbs tarlatamabandthefutureofimmunotherapyanewapproachtosmallcelllungcancer |